Showing results (1731-1740 of 1,852) with videos related to
Sort By:
Pageof 186
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 25, 2024
Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trialGiorgio Valabrega, Matthew A Powell, Sakari Hietanen, et al.The Lancet. Oncology|August 30, 2024
Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroupCarien L Creutzberg, Jae-Weon Kim, Gemma Eminowicz, et al.Blood|June 19, 2013
Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcriptionDaniel Thomas, Jason A Powell, Francois Vergez, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Ovarian cancer, version 2.2013Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.American Journal of Human Genetics|December 12, 2018
Variants in PUS7 Cause Intellectual Disability with Speech Delay, Microcephaly, Short Stature, and Aggressive BehaviorArjan P M de Brouwer, Rami Abou Jamra, Nadine Körtel, et al.Gynecologic Oncology|May 29, 2026
Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trialMatthew A Powell, Henrik Roed, Lyndsay J Willmott, et al.Annals of the American Thoracic Society|February 9, 2024
Peripheral Blood Mononuclear Cell Gene Expression Associated with Pulmonary Microvascular Perfusion: The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary DiseaseKristina L Buschur, Tess D Pottinger, Jens Vogel-Claussen, et al.Gynecologic Oncology|January 26, 2024
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypesStuart S Winkler, Chunqiao Tian, Yovanni Casablanca, et al.Gynecologic Oncology|November 12, 2024
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)Matthew A Powell, David Cibula, David M O'Malley, et al.Mayo Clinic Proceedings. Digital Health|March 9, 2026
State of the AI: Post-Deployment Monitoring of Radiology-Focused Internally Developed AICole J Cook, Jason R Klug, Blaize W Kandler, et al.Pageof 186